|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000166448 |
Summary for TMEM130 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000166448 | Gene symbol | TMEM130 |
| Gene name | transmembrane protein 130 | |
| HGNC | 25429 | |
| Entrez ID | 222865 | |
| Gene type | protein_coding | |
| Synonyms | TMEM130|DKFZp761L1417|FLJ42643 | |
| UniProtAcc | Q8N3G9 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for TMEM130 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for TMEM130 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for TMEM130 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg02132470 | chr7:98870415 | CGI:chr7:98869400-98870435 | UTR,promoter,exon,gene body | 8.18e-02 | 2.39e-01 | -2.24e+00 | 2.50e-02 | 3.81e-02 | -1.57e-01 |
| PAAD | cg19752627 | chr7:98869757 | CGI:chr7:98869400-98870435 | promoter,gene body | 1.73e-01 | 2.75e-01 | -2.59e+00 | 9.49e-03 | 2.43e-02 | -1.02e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BLCA | cg19752627 | chr7:98869757 | CGI:chr7:98869400-98870435 | promoter,gene body | 2.52e-01 | 3.72e-02 | 2.01e+00 | 4.45e-02 | 4.56e-02 | 2.14e-01 |
| LIHC | cg01307939 | chr7:98869948 | CGI:chr7:98869400-98870435 | UTR,promoter,exon,gene body | 1.77e-01 | 2.19e-02 | 2.96e+00 | 3.06e-03 | 4.27e-03 | 1.55e-01 |
| CHOL | cg19752627 | chr7:98869757 | CGI:chr7:98869400-98870435 | promoter,gene body | 2.25e-01 | 2.17e-02 | 2.80e+00 | 5.09e-03 | 1.63e-02 | 2.03e-01 |
| CHOL | cg05833635 | chr7:98869560 | CGI:chr7:98869400-98870435 | promoter,gene body | 3.75e-01 | 1.50e-01 | 1.99e+00 | 4.65e-02 | 4.65e-02 | 2.25e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg01307939 | chr7:98869948 | CGI:chr7:98869400-98870435 | UTR,promoter,exon,gene body | 1.43e-01 | 1.72e-02 | 8.57e+00 | 1.02e-17 | 4.60e-17 | 1.26e-01 |
| BRCA | cg19752627 | chr7:98869757 | CGI:chr7:98869400-98870435 | promoter,gene body | 1.75e-01 | 2.53e-02 | 9.37e+00 | 7.43e-21 | 4.32e-20 | 1.50e-01 |
| BRCA | cg05833635 | chr7:98869560 | CGI:chr7:98869400-98870435 | promoter,gene body | 2.68e-01 | 1.03e-01 | 8.27e+00 | 1.29e-16 | 5.32e-16 | 1.65e-01 |
| BRCA | cg06124528 | chr7:98870544 | CGI:chr7:98869400-98870435 | UTR,promoter,exon,gene body | 2.01e-01 | 6.34e-02 | 9.52e+00 | 1.79e-21 | 1.10e-20 | 1.38e-01 |
| BLCA | cg01307939 | chr7:98869948 | CGI:chr7:98869400-98870435 | UTR,promoter,exon,gene body | 1.88e-01 | 5.25e-02 | 2.14e+00 | 3.25e-02 | 3.74e-02 | 1.35e-01 |
| LIHC | cg05833635 | chr7:98869560 | CGI:chr7:98869400-98870435 | promoter,gene body | 2.23e-01 | 1.05e-01 | 2.21e+00 | 2.68e-02 | 3.04e-02 | 1.18e-01 |
Top |
Exon skipping events with PSI in TCGA for TMEM130 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for TMEM130 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for TMEM130 |
| TFs related to TMEM130. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| TMEM130 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for TMEM130 |
| RBPs related to ES in TMEM130. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| TMEM130 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs13234987 | chr7:99164783:C:T | - | 0.116137209424567 | 0.000733192082388933 | LUSC | Female-baised eQTL |
| rs34438515 | chr7:99162707:A:G | - | 0.115971248554889 | 0.000774041735328701 | LUSC | Female-baised eQTL |
| rs36126937 | chr7:99164188:T:C | - | 0.115971248554889 | 0.000774041735328701 | LUSC | Female-baised eQTL |
| rs71567525 | chr7:99165333:T:C | - | 0.115971248554889 | 0.000774041735328701 | LUSC | Female-baised eQTL |
| rs35957782 | chr7:99167545:C:T | - | 0.115971248554889 | 0.000774041735328701 | LUSC | Female-baised eQTL |
| rs71567527 | chr7:99179058:T:C | - | 0.115971248554889 | 0.000774041735328701 | LUSC | Female-baised eQTL |
| rs13235702 | chr7:99187703:G:T | - | 0.115806165333448 | 0.000815049368480647 | LUSC | Female-baised eQTL |
| rs34370403 | chr7:99182413:T:G | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs34281805 | chr7:99182436:T:C | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs13243515 | chr7:99182688:G:T | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs13243638 | chr7:99182772:G:T | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs10280956 | chr7:99182898:C:G | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs10237900 | chr7:99183128:T:C | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs10281925 | chr7:99183528:G:A | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs28592685 | chr7:99184127:A:G | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs34175806 | chr7:99184333:G:A | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs35072460 | chr7:99184443:G:A | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs35236657 | chr7:99184652:T:G | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs17161604 | chr7:99184727:G:T | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs10245912 | chr7:99184885:T:C | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs6465741 | chr7:99186461:G:A | - | 0.105132465465668 | 0.00356132756117588 | LUSC | Female-baised eQTL |
| rs73175865 | chr7:103424366:C:T | - | 0.0821305899040189 | 0.00798324075111887 | LUSC | Female-baised eQTL |
| rs12533510 | chr7:103421940:T:C | - | 0.0752632807792488 | 0.0156983576595362 | LUSC | Female-baised eQTL |
| rs17142677 | chr7:103416473:G:C | - | 0.0820445123459361 | 0.0172481481397544 | LUSC | Female-baised eQTL |
| rs2906637 | chr7:103425675:T:C | - | 0.0754298978255102 | 0.018891527836675 | LUSC | Female-baised eQTL |
| rs17143710 | chr7:103429986:C:A | - | 0.0754298978255102 | 0.018891527836675 | LUSC | Female-baised eQTL |
| rs12530735 | chr7:103421970:C:T | - | 0.0743223965909355 | 0.0214123380086721 | LUSC | Female-baised eQTL |
| rs34723720 | chr7:99181506:T:A | - | 0.0838179037608057 | 0.0372626711294968 | LUSC | Female-baised eQTL |
| rs3808019 | chr7:103934726:C:T | - | -0.0901416890045954 | 0.000202878624199392 | LUAD | Female-baised eQTL |
| rs183519186 | chr7:91367514:T:C | - | 0.0711815351307602 | 0.0155069273340274 | LUAD | Female-baised eQTL |
| rs2970477 | chr7:101943486:G:T | - | -0.0538873599784751 | 0.0234988293078733 | LUAD | Female-baised eQTL |
| rs10264151 | chr7:97874879:A:C | - | 0.0394696513146641 | 0.0328844578631166 | LUAD | Female-baised eQTL |
| rs62478704 | chr7:97882058:C:T | - | 0.0393352904549052 | 0.0333613504709143 | LUAD | Female-baised eQTL |
| rs73220743 | chr7:91364192:T:C | - | 0.0667208397927617 | 0.0348731085670621 | LUAD | Female-baised eQTL |
| rs10261245 | chr7:97861170:C:T | - | 0.0409075747897019 | 0.0415167042055855 | LUAD | Female-baised eQTL |
| rs10261265 | chr7:97861245:C:G | - | 0.0409075747897019 | 0.0415167042055855 | LUAD | Female-baised eQTL |
| rs17163874 | chr7:91365004:G:A | - | 0.064869570393572 | 0.0425538105080843 | LUAD | Female-baised eQTL |
| rs117704774 | chr7:91365383:G:A | - | 0.064869570393572 | 0.0425538105080843 | LUAD | Female-baised eQTL |
| rs75418203 | chr7:91379231:A:G | - | 0.0628757454304657 | 0.0494484705694606 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs940335 | chr7:99561710:G:C | - | 0.259635692521538 | 2.08182797906103e-06 | GBM | Male-baised eQTL |
| rs183803678 | chr7:93113189:A:G | - | 0.0616356055067173 | 0.000764489845413054 | LUSC | Male-baised eQTL |
| rs150844069 | chr7:93113574:C:T | - | 0.0616356055067173 | 0.000764489845413054 | LUSC | Male-baised eQTL |
| rs10488530 | chr7:93115815:T:C | - | 0.0616356055067173 | 0.000764489845413054 | LUSC | Male-baised eQTL |
| rs138546937 | chr7:93109642:A:C | - | 0.0603873346782032 | 0.00167420366975623 | LUSC | Male-baised eQTL |
| rs59001408 | chr7:93115063:C:T | - | 0.0446634657225163 | 0.0136676206209042 | LUSC | Male-baised eQTL |
| rs10225152 | chr7:95512968:G:A | - | 0.0351844174039712 | 0.0497432300916438 | LUSC | Male-baised eQTL |
| rs2969398 | chr7:96868393:T:C | - | -0.0819556380663458 | 0.0259448828691811 | LGG | Male-baised eQTL |
| rs111481275 | chr7:101348605:A:G | - | 0.0524971040675472 | 0.010501398308487 | LUAD | Male-baised eQTL |
| rs139437676 | chr7:101348750:C:T | - | 0.0524971040675472 | 0.010501398308487 | LUAD | Male-baised eQTL |
| rs142525517 | chr7:101348881:A:G | - | 0.0524971040675472 | 0.010501398308487 | LUAD | Male-baised eQTL |
| rs10953321 | chr7:101097352:T:G | - | 0.048597590962459 | 0.013669350992791 | LUAD | Male-baised eQTL |
| rs144275898 | chr7:101327289:A:G | - | 0.0710904428484831 | 0.0141277329241763 | LUAD | Male-baised eQTL |
| rs57739182 | chr7:101331605:G:T | - | 0.0710904428484831 | 0.0141277329241763 | LUAD | Male-baised eQTL |
| rs10248719 | chr7:101343011:G:A | - | 0.0492593108808963 | 0.0177474589042759 | LUAD | Male-baised eQTL |
| rs12705468 | chr7:108427508:A:G | - | -0.0733641942051727 | 0.0217917931831244 | LUAD | Male-baised eQTL |
| rs4730317 | chr7:108427723:A:C | - | -0.0733641942051727 | 0.0217917931831244 | LUAD | Male-baised eQTL |
| rs4730318 | chr7:108427773:A:G | - | -0.0733641942051727 | 0.0217917931831244 | LUAD | Male-baised eQTL |
| rs4730319 | chr7:108427969:T:C | - | -0.0733641942051727 | 0.0217917931831244 | LUAD | Male-baised eQTL |
| rs4727711 | chr7:108428129:T:G | - | -0.0733641942051727 | 0.0217917931831244 | LUAD | Male-baised eQTL |
| rs10240397 | chr7:108428245:G:A | - | -0.0733641942051727 | 0.0217917931831244 | LUAD | Male-baised eQTL |
| rs6466230 | chr7:108428390:A:G | - | -0.0733641942051727 | 0.0217917931831244 | LUAD | Male-baised eQTL |
| rs6466231 | chr7:108428595:T:C | - | -0.0733641942051727 | 0.0217917931831244 | LUAD | Male-baised eQTL |
| rs11760747 | chr7:101089040:C:T | - | 0.0457957301570109 | 0.0227545344705863 | LUAD | Male-baised eQTL |
| rs112038432 | chr7:101332481:G:A | - | 0.0656441463304937 | 0.0264435817226967 | LUAD | Male-baised eQTL |
| rs12334151 | chr7:101304866:C:T | - | 0.0453290795200291 | 0.0277350317561146 | LUAD | Male-baised eQTL |
| rs74199090 | chr7:101316578:G:A | - | 0.0638982323293787 | 0.0278151718595033 | LUAD | Male-baised eQTL |
| rs74503969 | chr7:101316964:T:G | - | 0.0638982323293787 | 0.0278151718595033 | LUAD | Male-baised eQTL |
| rs4729686 | chr7:101317269:G:A | - | 0.0638982323293787 | 0.0278151718595033 | LUAD | Male-baised eQTL |
| rs73180992 | chr7:101318592:A:G | - | 0.0638982323293787 | 0.0278151718595033 | LUAD | Male-baised eQTL |
| rs28456044 | chr7:101312399:C:T | - | 0.0446031480454233 | 0.0315540341198636 | LUAD | Male-baised eQTL |
| rs28557778 | chr7:101312690:C:A | - | 0.0446031480454233 | 0.0315540341198636 | LUAD | Male-baised eQTL |
| rs9769986 | chr7:101342207:T:C | - | 0.0460256802950786 | 0.0316010674498061 | LUAD | Male-baised eQTL |
| rs3988226 | chr7:101309422:A:C | - | 0.0445636479665593 | 0.0320847654356962 | LUAD | Male-baised eQTL |
| rs10235183 | chr7:101339409:C:G | - | 0.0452669846245548 | 0.0358829937761233 | LUAD | Male-baised eQTL |
| rs78388329 | chr7:101339706:C:G | - | 0.0452669846245548 | 0.0358829937761233 | LUAD | Male-baised eQTL |
| rs17135360 | chr7:101339942:C:T | - | 0.0452669846245548 | 0.0358829937761233 | LUAD | Male-baised eQTL |
| rs6942716 | chr7:101340103:G:A | - | 0.0452669846245548 | 0.0358829937761233 | LUAD | Male-baised eQTL |
| rs6942725 | chr7:101340125:G:T | - | 0.0452669846245548 | 0.0358829937761233 | LUAD | Male-baised eQTL |
| rs9769980 | chr7:101342077:T:A | - | 0.0452669846245548 | 0.0358829937761233 | LUAD | Male-baised eQTL |
| rs28719520 | chr7:101321441:G:A | - | 0.0454570779294597 | 0.0360090354561105 | LUAD | Male-baised eQTL |
| rs4729688 | chr7:101323126:T:C | - | 0.045477126048378 | 0.0360287177768595 | LUAD | Male-baised eQTL |
| rs77228011 | chr7:101327264:C:T | - | 0.045477126048378 | 0.0360287177768595 | LUAD | Male-baised eQTL |
| rs12538072 | chr7:101327864:C:A | - | 0.045477126048378 | 0.0360287177768595 | LUAD | Male-baised eQTL |
| rs10235434 | chr7:101339444:G:A | - | 0.0451107089470845 | 0.0371264840034399 | LUAD | Male-baised eQTL |
| rs73182905 | chr7:101340071:C:T | - | 0.0451107089470845 | 0.0371264840034399 | LUAD | Male-baised eQTL |
| rs80037075 | chr7:89139114:G:T | - | 0.04766815007792 | 0.0410449668052787 | LUAD | Male-baised eQTL |
| rs57348401 | chr7:89142868:C:G | - | 0.0477049770070864 | 0.0414226251143204 | LUAD | Male-baised eQTL |
| rs6466227 | chr7:108424279:T:C | - | -0.0592336696353608 | 0.0447251583569904 | LUAD | Male-baised eQTL |
| rs58660040 | chr7:101316084:C:T | - | 0.0434459464866846 | 0.0454794276652986 | LUAD | Male-baised eQTL |
| rs12667943 | chr7:101112428:T:C | - | 0.0406581977344784 | 0.0470457884506178 | LUAD | Male-baised eQTL |
| rs17398373 | chr7:89130310:T:C | - | 0.054455350396362 | 0.0471650267795182 | LUAD | Male-baised eQTL |
| rs10231243 | chr7:101338377:G:A | - | 0.0436149690995475 | 0.0474605936224148 | LUAD | Male-baised eQTL |
| rs57916806 | chr7:101320871:G:A | - | 0.0429837333510785 | 0.0478239312205286 | LUAD | Male-baised eQTL |
| rs66492618 | chr7:101105954:G:A | - | 0.040687500974219 | 0.047912635597031 | LUAD | Male-baised eQTL |
| rs4730310 | chr7:108425722:C:G | - | -0.0591213726775946 | 0.0485393024223427 | LUAD | Male-baised eQTL |
| rs67568738 | chr7:101106571:G:A | - | 0.0403891462322695 | 0.0491388260936657 | LUAD | Male-baised eQTL |
| rs73178519 | chr7:101107973:C:T | - | 0.0471227331215312 | 0.0495910006720826 | LUAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000166448 |
| CpG Site: cg11553793 | |
| Position to Gene: gene,exon,UTR | |
| Male Effect: -0.271152518735749 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg11553793 | chr7:98865909 | gene,exon,UTR | -0.271152518735749 | 1.87261263981516e-09 | -0.44515294471956013 | 2.9840994589094395e-12 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of TMEM130 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
